-
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart AssociationCB Newman and and on behalf of the American Heart Association Clinical Lipidology, Lipoprotein, Metabolism and Thrombosis Committee, a Joint Committee of the Council on Atherosclerosis, Thrombosis and Vascular Biology and Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular Disease in the Young; Council on Clinical Cardiology; and Stroke Council. -
Advances in Coronary No-Reflow Phenomenon-a Contemporary ReviewKarimianpour A, Maran A.
-
2-Year Outcomes After Stenting of Lipid-Rich and Nonrich Coronary PlaquesMHwa Yamamoto, A Maehara, GW Stone et al.
-
Coronary Artery Calcium Is Associated with Left Ventricular Diastolic Function Independent of Myocardial IschemiaNitta K, Kurisu S, Nakamoto Y et al.
-
Impact of lesion complexity on peri-procedural adverse events and the benefit of potent intravenous platelet adenosine diphosphate receptor inhibition after percutaneous coronary intervention: core laboratory analysis from 10 854 patients from the CHAMPION PHOENIX trialStone GW, Généreux P, Harrington RA et al.
-
Cardiovascular Biomarkers and Imaging in Older Adults: JACC Council PerspectivesDE Forman, JA de Lemos, and for the Geriatric Cardiology Section Leadership Council.
-
Qualitative Methodology in Cardiovascular Outcomes Research: A Contemporary LookMcIlvennan CK, Morris MA, Guetterman TC et al.
-
Management of Patients With NSTE-ACS: A Comparison of the Recent AHA/ACC and ESC GuidelinesRodriguez F, Mahaffey KW.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
